Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   
OVERLAP
39%

OVERLAP
BY WEIGHT
7

# OF OVERLAPPING
HOLDINGS
MEDX
27
HOLDINGS
26%
ALSO IN THNR
THNR
18
HOLDINGS
39%
ALSO IN MEDX
SECTOR DRIFT (MEDX minus THNR)
OVERLAPPING HOLDINGS

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in MEDX
Weight
in THNR
Overlap
ELI LILLY & CO 17.0% 15.6% 15.6%
ASTRAZENECA PLC-SPONS ADR 5.2% 5.2% 5.2%
ABBVIE INC 8.7% 4.8% 4.8%
AMGEN INC 3.9% 7.3% 3.9%
PFIZER INC 3.4% 4.9% 3.4%
MEDX Overweight Relative to THNR
NOVARTIS AG-ADR 6.4%
ALNYLAM PHARMACEUTICALS INC 5.7%
IONIS PHARMACEUTICALS, INC. 5.1%
JOHNSON & JOHNSON 4.9%
BRISTOL-MYERS SQUIBB CO 4.4%
ABBVIE INC 3.9%
ALKERMES PLC 3.4%
CRISPR THERAPEUTICS AG 3.0%
BIOGEN IDEC INC 2.8%
GLAXOSMITHKLINE PLC-SPON ADR 2.7%
MEDX Underweight Relative to THNR
NOVO-NORDISK A/S-SPONS ADR -10.3%
CHUGAI PHARMACEUTICAL CO LTD -7.3%
ROCHE HOLDING LTD -5.4%
REGENERON PHARMACEUTICALS -5.3%
INNOVENT BIOLOGICS, INC. -4.5%
SHIONOGI & CO LTD -4.4%
CHINA PHARMACEUTICAL GROUP -3.6%
HIMS & HERS HEALTH, INC. CLASS A -3.5%
AMGEN INC -3.4%
ZEALAND PHARMA A/S -3.2%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY